Cart

0

Business

“Eli Lilly Smashes Third-Quarter Forecasts As Diabetes [Drug] Blockbuster Grows 652%”

“…Mounjaro, Lilly’s new diabetes drug, brought in $1.41 billion in sales, growing 652% and coming in above estimates for $1.28 billion. Lilly is hoping the Food and Drug Administration will soon approve Mounjaro as a weight-loss drug…” https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2023/?src=A00220

Energy

“Exxon smashes Western oil majors’ earnings record with $56 billion profit for 2022”

“Exxon Mobil Corp posted a $56 billion profit for 2022, the company said on Tuesday, taking home about $6.3 million per hour last year, and setting not only a company record but a historic high for the Western oil industry.… Continue Reading…